Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran 1665659911, Iran.
Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran 1665659911, Iran.
Cells. 2021 Jul 8;10(7):1726. doi: 10.3390/cells10071726.
The lack of an appropriate platform for a better understanding of the molecular basis of hepatitis viruses and the absence of reliable models to identify novel therapeutic agents for a targeted treatment are the two major obstacles for launching efficient clinical protocols in different types of viral hepatitis. Viruses are obligate intracellular parasites, and the development of model systems for efficient viral replication is necessary for basic and applied studies. Viral hepatitis is a major health issue and a leading cause of morbidity and mortality. Despite the extensive efforts that have been made on fundamental and translational research, traditional models are not effective in representing this viral infection in a laboratory. In this review, we discuss in vitro cell-based models and in vivo animal models, with their strengths and weaknesses. In addition, the most important findings that have been retrieved from each model are described.
缺乏更好地理解肝炎病毒分子基础的适当平台,以及缺乏可靠的模型来鉴定针对特定治疗的新型治疗药物,这是启动不同类型病毒性肝炎有效临床方案的两大障碍。病毒是专性细胞内寄生虫,为了进行基础和应用研究,开发有效的病毒复制模型系统是必要的。病毒性肝炎是一个主要的健康问题,也是发病率和死亡率的主要原因。尽管在基础和转化研究方面已经做出了广泛的努力,但传统模型在实验室中不能有效地代表这种病毒感染。在这篇综述中,我们讨论了基于细胞的体外模型和体内动物模型,以及它们的优缺点。此外,还描述了从每种模型中获得的最重要的发现。